Man Group
TARO

Man Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Man Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-37,682
Closed -$3.7M – 2161
2018
Q3 		$3.7M Sell
37,682
-10,445
-22% -$1.13M 0.01% 1157
2018
Q2 		$5.57M Buy
48,127
+22,981
+91% +$2.52M 0.02% 886
2018
Q1 		$2.48M Buy
+25,146
New +$2.55M 0.01% 1198

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Man Group's TARO Position: Q4 2018 in Review

Man Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 37,682 shares — an estimated $3.7M sold.

Man Group first reported a position in TARO in Q1 2018 and held it in 3 quarters. The position peaked at $5.57M in Q2 2018. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

  • Man Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
  • Man Group sold 37,682 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $3.7M.
  • Man Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2018 and held it in 3 quarters.
  • Man Group's Taro Pharmaceutical Industries Ltd. position peaked at $5.57M in Q2 2018.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on Man Group's 13F filing for Q4 2018, filed 14 Feb 2019.